Everion Pharmaceuticals COO Announces 30% Company-Wide Promotion Across Expanded Research Portfolio
Alina Khomenko, Chief Operating Officer, Everion Pharmaceuticals. Photo courtesy of Everion Pharmaceuticals.
UNITED STATES – September 29, 2026 – Everion Pharmaceuticals today announced a 30% promotional discount across eligible participating products in its research portfolio, introduced by the company’s newly appointed Chief Operating Officer, Alina Khomenko.
Using promotional code GET30OFF, eligible customers can receive 30% off participating products through EverionPharma.com for the promotional period.
“Growth only matters when the people we serve benefit from it,” said Alina Khomenko, Chief Operating Officer of Everion Pharmaceuticals. “As I begin this new chapter with Everion, I want our customers and research partners to see immediately what our priorities are: accessibility, quality, transparency and continued innovation. This promotion introduces more researchers to the breadth of the expanding Everion portfolio.”
UNLOCK HUMAN POTENTIAL – 30% OFF PROMOTIONAL CODE: GET30OFF
Expanded Research Portfolio
Everion’s expanding portfolio includes Semaglutide, Tirzepatide, Retatrutide, BPC-157, TB-500, CJC-1295, Ipamorelin, Tesamorelin, Sermorelin, MOTS-C, GHK-Cu, NAD+, AOD-9604, 5-Amino-1MQ, Thymosin Alpha-1, DSIP, LL-37, Semax, Selank, Pinealon, Kisspeptin-10, IGF-1 LR3, HGH 191AA, PT-141, Oxytocin Acetate and Melanotan II, among other products in the Everion research portfolio.
Products described as research products are presented for research purposes. Product status, eligibility and promotional availability may vary.
A New Chapter for Everion
Khomenko’s appointment comes during a period of continued development for Everion Pharmaceuticals as the company works to strengthen its international footprint and build relationships across research, pharmaceutical and wellness markets.
Her responsibilities as COO include helping oversee international operations, organizational development, strategic partnerships and the continued expansion of Everion’s global business infrastructure.
“We are building Everion for the future,” said Samier Tadros, Founder, Chairman, President & CEO of Everion Pharmaceuticals. “Alina brings an international perspective, tremendous energy and a commitment to execution. This promotion is only the beginning of what our customers will see as we continue expanding the company.”
“Everion’s mission is captured in three words: Unlock Human Potential. My responsibility as COO is to help turn those words into action – through stronger operations, international growth and a company that never stops looking for ways to better serve the research community,” Khomenko added.
About Everion Pharmaceuticals
Everion Pharmaceuticals is a research pharmaceutical company focused on providing research products while expanding its international operations and distribution network. The company continues to invest in product availability, quality standards, laboratory documentation, customer service and global growth.
Promotional Code: GET30OFF
For more information visiit website: EverionPharma.com or send an email via Kimberly.wheeler@everionpharma.com.
Media Contact
Company Name: Everion Pharmaceuticals
Contact Person: Kimberly Wheeler
Email: Send Email
Phone: +1 (754) 457-3468
Country: United States
Website: EverionPharma.com
